240 related articles for article (PubMed ID: 27250577)
1. Usefulness of positron emission tomographic studies for gliomas.
Miyake K; Ogawa D; Okada M; Hatakeyama T; Tamiya T
Neurol Med Chir (Tokyo); 2016 Jul; 56(7):396-408. PubMed ID: 27250577
[TBL] [Abstract][Full Text] [Related]
2. From the clinician's point of view - What is the status quo of positron emission tomography in patients with brain tumors?
Galldiks N; Langen KJ; Pope WB
Neuro Oncol; 2015 Nov; 17(11):1434-44. PubMed ID: 26130743
[TBL] [Abstract][Full Text] [Related]
3. [Use of amino acid PET in the Diagnostic and Treatment Management of cerebral gliomas].
Galldiks N; Langen KJ
Fortschr Neurol Psychiatr; 2012 Jan; 80(1):17-23. PubMed ID: 22161228
[TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography for radiation treatment planning.
Grosu AL; Piert M; Weber WA; Jeremic B; Picchio M; Schratzenstaller U; Zimmermann FB; Schwaiger M; Molls M
Strahlenther Onkol; 2005 Aug; 181(8):483-99. PubMed ID: 16044216
[TBL] [Abstract][Full Text] [Related]
5. Brain Tumors: An Update on Clinical PET Research in Gliomas.
Herholz K
Semin Nucl Med; 2017 Jan; 47(1):5-17. PubMed ID: 27987557
[TBL] [Abstract][Full Text] [Related]
6. Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.
Albert NL; Weller M; Suchorska B; Galldiks N; Soffietti R; Kim MM; la Fougère C; Pope W; Law I; Arbizu J; Chamberlain MC; Vogelbaum M; Ellingson BM; Tonn JC
Neuro Oncol; 2016 Sep; 18(9):1199-208. PubMed ID: 27106405
[TBL] [Abstract][Full Text] [Related]
7. Molecular imaging (PET) of brain tumors.
Basu S; Alavi A
Neuroimaging Clin N Am; 2009 Nov; 19(4):625-46. PubMed ID: 19959009
[TBL] [Abstract][Full Text] [Related]
8. 11C-CHO PET in optimization of target volume delineation and treatment regimens in postoperative radiotherapy for brain gliomas.
Li FM; Nie Q; Wang RM; Chang SM; Zhao WR; Zhu Q; Liang YK; Yang P; Zhang J; Jia HW; Fang HH
Nucl Med Biol; 2012 Apr; 39(3):437-42. PubMed ID: 22172386
[TBL] [Abstract][Full Text] [Related]
9. PET and SPECT studies in children with hemispheric low-grade gliomas.
Juhász C; Bosnyák E
Childs Nerv Syst; 2016 Oct; 32(10):1823-32. PubMed ID: 27659825
[TBL] [Abstract][Full Text] [Related]
10. Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas.
Borbély K; Nyáry I; Tóth M; Ericson K; Gulyás B
J Neurol Sci; 2006 Jul; 246(1-2):85-94. PubMed ID: 16603193
[TBL] [Abstract][Full Text] [Related]
11. An interindividual comparison of O-(2-[18F]fluoroethyl)-L-tyrosine (FET)- and L-[methyl-11C]methionine (MET)-PET in patients with brain gliomas and metastases.
Grosu AL; Astner ST; Riedel E; Nieder C; Wiedenmann N; Heinemann F; Schwaiger M; Molls M; Wester HJ; Weber WA
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1049-58. PubMed ID: 21570201
[TBL] [Abstract][Full Text] [Related]
12. Amino Acid Tracer PET MRI in Glioma Management: What a Neuroradiologist Needs to Know.
Soni N; Ora M; Jena A; Rana P; Mangla R; Ellika S; Almast J; Puri S; Meyers SP
AJNR Am J Neuroradiol; 2023 Mar; 44(3):236-246. PubMed ID: 36657945
[TBL] [Abstract][Full Text] [Related]
13. Clinical value of O-(2-[(18)F]-fluoroethyl)-L-tyrosine positron emission tomography in patients with low-grade glioma.
Rapp M; Floeth FW; Felsberg J; Steiger HJ; Sabel M; Langen KJ; Galldiks N
Neurosurg Focus; 2013 Feb; 34(2):E3. PubMed ID: 23373448
[TBL] [Abstract][Full Text] [Related]
14. Non-routine Tracers for PET Imaging of High-grade Glioma.
Frosina G
Anticancer Res; 2016 Jul; 36(7):3253-60. PubMed ID: 27354581
[TBL] [Abstract][Full Text] [Related]
15. 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors.
Jacobs AH; Thomas A; Kracht LW; Li H; Dittmar C; Garlip G; Galldiks N; Klein JC; Sobesky J; Hilker R; Vollmar S; Herholz K; Wienhard K; Heiss WD
J Nucl Med; 2005 Dec; 46(12):1948-58. PubMed ID: 16330557
[TBL] [Abstract][Full Text] [Related]
16. Imaging gliomas with positron emission tomography and single-photon emission computed tomography.
Bénard F; Romsa J; Hustinx R
Semin Nucl Med; 2003 Apr; 33(2):148-62. PubMed ID: 12756647
[TBL] [Abstract][Full Text] [Related]
17. [Diagnosis and prognosis in neuro-oncology: contribution of positron emission tomography].
Derlon JM
Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 1):854-7. PubMed ID: 11677408
[TBL] [Abstract][Full Text] [Related]
18. [Combined use of positron emission tomography with (18)F-fluorodeoxyglucose and (11)C-methionine for preoperative evaluation of gliomas].
Yamaguchi S; Terasaka S; Kobayashi H; Narita T; Hirata K; Shiga S; Usui R; Tanaka S; Kubota K; Murata J; Asaoka K
No Shinkei Geka; 2010 Jul; 38(7):621-8. PubMed ID: 20628188
[TBL] [Abstract][Full Text] [Related]
19. Clinical applications of PET in brain tumors.
Chen W
J Nucl Med; 2007 Sep; 48(9):1468-81. PubMed ID: 17704239
[TBL] [Abstract][Full Text] [Related]
20. Comparison of (18)F-FET and (18)F-FDG PET in brain tumors.
Pauleit D; Stoffels G; Bachofner A; Floeth FW; Sabel M; Herzog H; Tellmann L; Jansen P; Reifenberger G; Hamacher K; Coenen HH; Langen KJ
Nucl Med Biol; 2009 Oct; 36(7):779-87. PubMed ID: 19720290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
